Literature DB >> 15466825

Axillary sentinel node and tumour-related factors associated with non-sentinel node involvement in breast cancer.

Gábor Cserni1, Tomasz Burzykowski, Vincent Vinh-Hung, Lajos Kocsis, Gábor Boross, Mária Sinkó, Miklós Tarján, Rita Bori, Mária Rajtár, Eliza Tekle, Róbert Maráz, Béla Baltás, Mihály Svébis.   

Abstract

BACKGROUND: After completion of axillary dissection, many breast cancer patients with axillary sentinel nodal involvement are found to have regional disease limited to the sentinel nodes. These patients are exposed to the morbidity of axillary clearance without any expected therapeutic benefit.
METHODS: Sentinel node biopsy was performed either with Patent blue dye or with a combined dye, radiocolloid and gamma-probe-guided method involving peritumoral tracer administration. For a series of 150 consecutive patients with involved axillary sentinel nodes and axillary dissection, factors associated with non-sentinel nodal involvement were analysed in a multivariate analysis based on logistic regression with the use of fractional polynomials.
RESULTS: The following variables were found to be potentially associated with non-sentinel node metastases: tumour size, sentinel node metastasis size, number of examined sentinel nodes, percentage of involved sentinel nodes (the latter two were found to be significant only when in combination), and extracapsular perinodal spread.
CONCLUSIONS: Isolated tumour cells and micrometastases in axillary sentinel nodes carry a low risk of non-sentinel node metastasis. The risk of metastasis to further echelon nodes is higher with macrometastases, especially if there is extracapsular growth and the proportion of involved sentinel nodes is high.

Entities:  

Mesh:

Year:  2004        PMID: 15466825     DOI: 10.1093/jjco/hyh090

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  10 in total

1.  Regional Disease Control in Selected Patients with Sentinel Lymph Node Involvement and Omission of Axillary Lymph Node Dissection.

Authors:  Gábor Cserni; Róbert Maráz
Journal:  Pathol Oncol Res       Date:  2015-02-04       Impact factor: 3.201

2.  Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study.

Authors:  Gábor Cserni; Simonetta Bianchi; Vania Vezzosi; Riccardo Arisio; Rita Bori; Johannes L Peterse; Anna Sapino; Isabella Castellano; Maria Drijkoningen; Janina Kulka; Vincenzo Eusebi; Maria P Foschini; Jean-Pierre Bellocq; Cristi Marin; Sten Thorstenson; Isabel Amendoeira; Angelika Reiner-Concin; Thomas Decker; Manuela Lacerda; Paulo Figueiredo; Gábor Fejes
Journal:  Pathol Oncol Res       Date:  2007-03-27       Impact factor: 3.201

3.  Analysis of molecular markers as predictive factors of lymph node involvement in breast carcinoma.

Authors:  Luciana Marques Paula; Luis Henrique Ferreira De Moraes; Abaeté Leite Do Canto; Laurita Dos Santos; Airton Abrahão Martin; Silvia Regina Rogatto; Renata De Azevedo Canevari
Journal:  Oncol Lett       Date:  2016-11-28       Impact factor: 2.967

4.  In breast cancer patients sentinel lymph node metastasis characteristics predict further axillary involvement.

Authors:  Ildiko Illyes; Anna-Maria Tokes; Attila Kovacs; A Marcell Szasz; Bela A Molnar; Istvan A Molnar; Ilona Kaszas; Zsuzsanna Baranyak; Zsolt Laszlo; Istvan Kenessey; Janina Kulka
Journal:  Virchows Arch       Date:  2014-05-09       Impact factor: 4.064

5.  Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors?

Authors:  J L Fougo; M Afonso; F Senhorães Senra; T Dias; C Leal; C Araújo; M Dinis-Ribeiro
Journal:  Clin Transl Oncol       Date:  2009-03       Impact factor: 3.405

6.  Eight-year experience with the intraoperative frozen section examination of sentinel lymph node biopsy for breast cancer in a North-Italian university center.

Authors:  Carla Cedolini; Serena Bertozzi; Luca Seriau; Ambrogio P Londero; Serena Concina; Federico Cattin; Onelio Geatti; Carla Di Loreto; Andrea Risaliti
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

Review 7.  Non-sentinel lymph node metastases associated with isolated breast cancer cells in the sentinel node.

Authors:  Carolien H M van Deurzen; Maaike de Boer; Evelyn M Monninkhof; Peter Bult; Elsken van der Wall; Vivianne C G Tjan-Heijnen; Paul J van Diest
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

8.  Ratios of involved nodes in early breast cancer.

Authors:  Vincent Vinh-Hung; Claire Verschraegen; Donald I Promish; Gábor Cserni; Jan Van de Steene; Patricia Tai; Georges Vlastos; Mia Voordeckers; Guy Storme; Melanie Royce
Journal:  Breast Cancer Res       Date:  2004-10-06       Impact factor: 6.466

9.  Subtype is a predictive factor of nonsentinel lymph node involvement in sentinel node-positive breast cancer patients.

Authors:  Kaptan Gülben; Uğur Berberoğlu; Ogün Aydoğan; Volkan Kınaş
Journal:  J Breast Cancer       Date:  2014-12-26       Impact factor: 3.588

10.  Molecular subtype classification is a determinant of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes.

Authors:  Wenbin Zhou; Zhongyuan He; Jialei Xue; Minghai Wang; Xiaoming Zha; Lijun Ling; Lin Chen; Shui Wang; Xiaoan Liu
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.